{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:49:12Z","timestamp":1763016552226},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2005,3,21]],"date-time":"2005-03-21T00:00:00Z","timestamp":1111363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,3,21]],"date-time":"2005-03-21T00:00:00Z","timestamp":1111363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2005,5,1]]},"DOI":"10.1038\/sj.bmt.1704930","type":"journal-article","created":{"date-parts":[[2005,3,21]],"date-time":"2005-03-21T10:03:31Z","timestamp":1111399411000},"page":"915-920","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity"],"prefix":"10.1038","volume":"35","author":[{"given":"G","family":"Eissner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Iacobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Bl\u00fcml","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Andreesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Holler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,3,21]]},"reference":[{"issue":"Suppl. 1","key":"BF1704930_CR1","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1038\/sj.thj.6200393","volume":"5","author":"AM Carella","year":"2004","unstructured":"Carella AM . Treatment of hematological malignancies with allogeneic nonmyeloablative stem cell transplantation: conditioning regimens with fludarabine. Hematol J 2004; 5 (Suppl. 1): S68\u2013S75.","journal-title":"Hematol J"},{"key":"BF1704930_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF02983793","volume":"78","author":"JL Ferrara","year":"2003","unstructured":"Ferrara JL, Cooke KR, Teshima T . The pathophysiology of acute graft-versus-host disease. Int J Hematol 2003; 78: 181\u2013187.","journal-title":"Int J Hematol"},{"key":"BF1704930_CR3","first-page":"277","volume":"2","author":"SI Bearman","year":"2003","unstructured":"Bearman SI . Reduced-intensity allogeneic stem cell transplantation. Curr Hematol Rep 2003; 2: 277\u2013286.","journal-title":"Curr Hematol Rep"},{"key":"BF1704930_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1182\/blood.V100.1.334","volume":"100","author":"G Eissner","year":"2002","unstructured":"Eissner G, Multhoff G, Gerbitz A et al. Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood 2002; 100: 334\u2013340.","journal-title":"Blood"},{"key":"BF1704930_CR5","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.V73.7.2018.2018","volume":"73","author":"E Holler","year":"1989","unstructured":"Holler E, Kolb HJ, Hiller E et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989; 73: 2018\u20132024.","journal-title":"Blood"},{"key":"BF1704930_CR6","first-page":"737","volume":"92","author":"PG Richardson","year":"1998","unstructured":"Richardson PG, Elias AD, Krishnan A et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998; 92: 737\u2013744.","journal-title":"Blood"},{"key":"BF1704930_CR7","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Murakami C, Jin Z et al. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 2002; 100: 4337\u20134343.","journal-title":"Blood"},{"key":"BF1704930_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00024382-199501000-00002","volume":"3","author":"C Skurk","year":"1995","unstructured":"Skurk C, Nuss C, Lefer AM . Beneficial effects of oligotide, a novel oligodeoxyribonucleotide, in murine traumatic shock. Shock 1995; 3: 13\u201320.","journal-title":"Shock"},{"key":"BF1704930_CR9","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1172\/JCI8296","volume":"105","author":"T Murohara","year":"2000","unstructured":"Murohara T, Ikeda H, Duan J et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527\u20131536.","journal-title":"J Clin Invest"},{"key":"BF1704930_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/0049-3848(95)99609-C","volume":"78","author":"G Rossoni","year":"1995","unstructured":"Rossoni G, Berti F, Berti M et al. Oligotide, a new single-stranded oligodeoxyribonucleotide, preserves postsynaptic beta-adrenergic and cholinergic receptor functions in rabbit hearts after acute infarction. Thromb Res 1995; 78: 429\u2013440.","journal-title":"Thromb Res"},{"key":"BF1704930_CR11","first-page":"301","volume":"28","author":"A Marni","year":"1996","unstructured":"Marni A, Forti D, Calvillo L et al. Anti-ischemic effect of oligotide treatment in rat kidney: comparison with the effect of nifedipine and isosorbide dinitrate. Transplant Proc 1996; 28: 301\u2013303.","journal-title":"Transplant Proc"},{"key":"BF1704930_CR12","first-page":"297","volume":"28","author":"A Marni","year":"1996","unstructured":"Marni A, Forti D, Cavillo L et al. Protection of rat kidney from ischemia reperfusion injury by oligotide. Transplant Proc 1996; 28: 297\u2013300.","journal-title":"Transplant Proc"},{"key":"BF1704930_CR13","first-page":"339","volume":"28","author":"F Pellegatta","year":"1996","unstructured":"Pellegatta F, Ferrero E, Marni A et al. Oligotide anti-ischemic effect is related to in vitro inhibition of leukocyte-endothelial cell adhesion. Transplant Proc 1996; 28: 339\u2013341.","journal-title":"Transplant Proc"},{"key":"BF1704930_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0014-2999(95)00695-8","volume":"296","author":"R Scalia","year":"1996","unstructured":"Scalia R, Gauthier TW, Murohara T, Lefer AM . Oligotide attenuates leukocyte-endothelial cell interaction via P-selectin in the rat mesenteric vascular bed. Eur J Pharmacol 1996; 296: 181\u2013187.","journal-title":"Eur J Pharmacol"},{"issue":"Suppl. 1","key":"BF1704930_CR15","doi-asserted-by":"publisher","first-page":"S420","DOI":"10.1111\/j.1432-2277.1996.tb01666.x","volume":"9","author":"F Pellegatta","year":"1996","unstructured":"Pellegatta F, Ferrero E, Marni A et al. The anti-ischemic drugs defibrotide and oligotide analogously inhibit leukocyte-endothelial cell adhesion in vitro. Transpl Int 1996; 9 (Suppl. 1): S420\u2013S424.","journal-title":"Transpl Int"},{"key":"BF1704930_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/1523-1747.ep12613748","volume":"99","author":"EW Ades","year":"1992","unstructured":"Ades EW, Candal FJ, Swerlick RA et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992; 99: 683\u2013690.","journal-title":"J Invest Dermatol"},{"key":"BF1704930_CR17","first-page":"997","volume":"52","author":"TG Cotter","year":"1992","unstructured":"Cotter TG, Lennon SV, Glynn JM, Green DR . Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res 1992; 52: 997\u20131005.","journal-title":"Cancer Res"},{"key":"BF1704930_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jlb.54.4.283","volume":"54","author":"A Lee","year":"1993","unstructured":"Lee A, Whyte MK, Haslett C . Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993; 54: 283\u2013288.","journal-title":"J Leukoc Biol"},{"key":"BF1704930_CR19","first-page":"553","volume":"80","author":"IN Bird","year":"1993","unstructured":"Bird IN, Spragg JH, Ager A, Matthews N . Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology 1993; 80: 553\u2013560.","journal-title":"Immunology"},{"key":"BF1704930_CR20","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.4049\/jimmunol.156.4.1515","volume":"156","author":"ME Berman","year":"1996","unstructured":"Berman ME, Xie Y, Muller WA . Roles of platelet\/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation. J Immunol 1996; 156: 1515\u20131524.","journal-title":"J Immunol"},{"key":"BF1704930_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1084\/jem.140.3.718","volume":"140","author":"HR MacDonald","year":"1974","unstructured":"MacDonald HR, Engers HD, Cerottini JC, Brunner KT . Generation of cytotoxic T lymphocytes in vitro. II. Effect of repeated exposure to alloantigens on the cytotoxic activity of long-term mixed leukocyte cultures. J Exp Med 1974; 140: 718\u2013730.","journal-title":"J Exp Med"},{"key":"BF1704930_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/00007890-199609270-00020","volume":"62","author":"G Eissner","year":"1996","unstructured":"Eissner G, Lindner H, Behrends U et al. Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: protective role of IL-10. Transplantation 1996; 62: 819\u2013827.","journal-title":"Transplantation"},{"key":"BF1704930_CR23","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1097\/00007890-199711150-00023","volume":"64","author":"H Lindner","year":"1997","unstructured":"Lindner H, Holler E, Gerbitz A et al. Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: interleukin-10 protects against transendothelial migration. Transplantation 1997; 64: 1370\u20131373.","journal-title":"Transplantation"},{"key":"BF1704930_CR24","first-page":"1731","volume":"2","author":"A Sandoval","year":"1996","unstructured":"Sandoval A, Consoli U, Plunkett W . Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes. Clin Cancer Res 1996; 2: 1731\u20131741.","journal-title":"Clin Cancer Res"},{"key":"BF1704930_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0027-5107(89)90090-0","volume":"210","author":"P Huang","year":"1989","unstructured":"Huang P, Siciliano MJ, Plunkett W . Gene deletion, a mechanism of induced mutation by arabinosyl nucleosides. Mutat Res 1989; 210: 291\u2013301.","journal-title":"Mutat Res"},{"key":"BF1704930_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1074\/jbc.275.1.29","volume":"275","author":"D Genini","year":"2000","unstructured":"Genini D, Budihardjo I, Plunkett W et al. Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway. J Biol Chem 2000; 275: 29\u201334.","journal-title":"J Biol Chem"},{"key":"BF1704930_CR27","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1182\/blood.V86.11.4184.bloodjournal86114184","volume":"86","author":"G Eissner","year":"1995","unstructured":"Eissner G, Kohlhuber F, Grell M et al. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 1995; 86: 4184\u20134193.","journal-title":"Blood"},{"key":"BF1704930_CR28","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood.V89.6.1931","volume":"89","author":"H Lindner","year":"1997","unstructured":"Lindner H, Holler E, Ertl B et al. Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines. Blood 1997; 89: 1931\u20131938.","journal-title":"Blood"},{"key":"BF1704930_CR29","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","volume":"111","author":"R Chopra","year":"2000","unstructured":"Chopra R, Eaton JD, Grassi A et al. Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol 2000; 111: 1122\u20131129.","journal-title":"Br J Haematol"},{"key":"BF1704930_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/1024533031000084231","volume":"8","author":"M Kaleelrahman","year":"2003","unstructured":"Kaleelrahman M, Eaton JD, Leeming D et al. Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF). Hematology 2003; 8: 91\u201395.","journal-title":"Hematology"},{"key":"BF1704930_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","volume":"10","author":"Y Chalandon","year":"2004","unstructured":"Chalandon Y, Roosnek E, Mermillod B et al. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 347\u2013354.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704930","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704930.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704930.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T03:46:11Z","timestamp":1706067971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,21]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,5,1]]}},"alternative-id":["BF1704930"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704930","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,21]]},"assertion":[{"value":"13 September 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}